Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SCANVET ANIMAL HEALTH A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   0.3% 1.8% 2.2% 1.8% 0.4% 0.4% 6.3% 6.3%   Credit score (0-100)   100 73 66 70 100 100 37 37   Credit rating   AAA A BBB A AAA AAA BBB BBB   Credit limit (kDKK)   32,102.6 120.3 20.0 211.7 60,368.4 69,619.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   65,720 0.0 0.0 0.0 62,409 63,785 0.0 0.0   EBITDA   39,274 32,636 26,371 24,785 42,458 44,231 0.0 0.0   EBIT   27,655 32,636 26,371 24,785 31,765 34,082 0.0 0.0   Pre-tax profit (PTP)   26,963.1 26,452.0 178,394.0 15,162.0 54,846.3 132,308.1 0.0 0.0   Net earnings   21,031.8 26,452.0 178,394.0 15,162.0 48,595.8 106,140.0 0.0 0.0   Pre-tax profit without non-rec. items   26,963 32,636 26,371 24,785 54,846 132,308 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Tangible assets total   50,368 0.0 0.0 0.0 51,400 52,737 0.0 0.0   Shareholders equity total   268,019 275,157 454,416 469,578 518,174 624,314 594,716 594,716   Interest-bearing liabilities   13,028 0.0 0.0 0.0 426 352 0.0 0.0   Balance sheet total (assets)   320,626 323,074 494,263 502,576 538,394 669,299 594,716 594,716   Net Debt   -83,416 0.0 0.0 0.0 -342,784 -433,403 -594,716 -594,716     See the entire balance sheet 1000.0 Volume  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   65,720 0.0 0.0 0.0 62,409 63,785 0.0 0.0   Gross profit growth   13.0% -100.0% 0.0% 0.0% 0.0% 2.2% -100.0% 0.0%   Employees   33 33 33 33 32 29 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -3.0% -9.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   320,626 323,074 494,263 502,576 538,394 669,299 594,716 594,716   Balance sheet change%   10.5% 0.8% 53.0% 1.7% 7.1% 24.3% -11.1% 0.0%   Added value   39,274.0 32,636.0 26,371.0 24,785.0 31,765.5 38,731.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -15,112 -50,368 0 0 47,761 -3,312 -52,737 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   42.1% 0.0% 0.0% 0.0% 50.9% 53.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.3% 10.1% 6.5% 5.0% 16.1% 23.2% 0.0% 0.0%   ROI %   11.8% 10.8% 6.5% 5.0% 16.4% 24.5% 0.0% 0.0%   ROE %   8.2% 9.7% 48.9% 3.3% 9.8% 18.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Equity ratio %   83.6% 100.0% 100.0% 100.0% 96.2% 93.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -212.4% 0.0% 0.0% 0.0% -807.3% -979.9% 0.0% 0.0%   Gearing %   4.9% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   52.9% 0.0% 0.0% 0.0% 13,666.6% 2,012.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Quick Ratio   2.5 0.0 0.0 0.0 18.5 10.7 0.0 0.0   Current Ratio   4.6 0.0 0.0 0.0 23.3 13.0 0.0 0.0   Cash and cash equivalent   96,444.5 0.0 0.0 0.0 343,209.6 433,755.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   147,175.2 0.0 0.0 0.0 222,285.0 196,750.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/5 2019 2020/5 2020 2021/5 2021 2022/5 2022 2023/5 2023 2024/5 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,190 989 799 751 993 1,336 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,190 989 799 751 1,327 1,525 0 0   EBIT / employee   838 989 799 751 993 1,175 0 0   Net earnings / employee   637 802 5,406 459 1,519 3,660 0 0